Ascending Dose Study of the Safety and Tolerability of REGN6490 in Healthy Volunteers
Clinical trial NCT04616079 · TERMINATED
Trial details
- NCT number
- NCT04616079
- Sponsor
- Regeneron Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-19
- Primary completion
- 2021-06-01
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.